1. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017
- Author
-
Carrie K, Shapiro-Mendoza, Marion E, Rice, Romeo R, Galang, Anna C, Fulton, Kelley, VanMaldeghem, Miguel Valencia, Prado, Esther, Ellis, Magele Scott, Anesi, Regina M, Simeone, Emily E, Petersen, Sascha R, Ellington, Abbey M, Jones, Tonya, Williams, Sarah, Reagan-Steiner, Janice, Perez-Padilla, Carmen C, Deseda, Andrew, Beron, Aifili John, Tufa, Asher, Rosinger, Nicole M, Roth, Caitlin, Green, Stacey, Martin, Camille Delgado, Lopez, Leah, deWilde, Mary, Goodwin, H Pamela, Pagano, Cara T, Mai, Carolyn, Gould, Sherif, Zaki, Leishla Nieves, Ferrer, Michelle S, Davis, Eva, Lathrop, Kara, Polen, Janet D, Cragan, Megan, Reynolds, Kimberly B, Newsome, Mariam Marcano, Huertas, Julu, Bhatangar, Alma Martinez, Quiñones, John F, Nahabedian, Laura, Adams, Tyler M, Sharp, W Thane, Hancock, Sonja A, Rasmussen, Cynthia A, Moore, Denise J, Jamieson, Jorge L, Munoz-Jordan, Helentina, Garstang, Afeke, Kambui, Carolee, Masao, Margaret A, Honein, Dana, Meaney-Delman, and Vikram, Krishnasamy
- Subjects
0301 basic medicine ,Zika virus disease ,medicine.medical_specialty ,Microcephaly ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,Prenatal care ,Asymptomatic ,Zika virus ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Pregnancy ,medicine ,Humans ,030212 general & internal medicine ,Full Report ,Pregnancy Complications, Infectious ,biology ,Transmission (medicine) ,Obstetrics ,business.industry ,Zika Virus Infection ,Infant, Newborn ,Pregnancy Outcome ,Gestational age ,General Medicine ,biology.organism_classification ,medicine.disease ,United States ,Surgery ,030104 developmental biology ,Female ,medicine.symptom ,business - Abstract
Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for Zika virus infection, which can lead to severe fetal and infant brain abnormalities and microcephaly (1). In February 2016, CDC recommended 1) routine testing for Zika virus infection of asymptomatic pregnant women living in areas with ongoing local Zika virus transmission at the first prenatal care visit, 2) retesting during the second trimester for women who initially test negative, and 3) testing of pregnant women with signs or symptoms consistent with Zika virus disease (e.g., fever, rash, arthralgia, or conjunctivitis) at any time during pregnancy (2). To collect information about pregnant women with laboratory evidence of recent possible Zika virus infection* and outcomes in their fetuses and infants, CDC established pregnancy and infant registries (3). During January 1, 2016-April 25, 2017, U.S. territories† with local transmission of Zika virus reported 2,549 completed pregnancies§ (live births and pregnancy losses at any gestational age) with laboratory evidence of recent possible Zika virus infection; 5% of fetuses or infants resulting from these pregnancies had birth defects potentially associated with Zika virus infection¶ (4,5). Among completed pregnancies with positive nucleic acid tests confirming Zika infection identified in the first, second, and third trimesters, the percentage of fetuses or infants with possible Zika-associated birth defects was 8%, 5%, and 4%, respectively. Among liveborn infants, 59% had Zika laboratory testing results reported to the pregnancy and infant registries. Identification and follow-up of infants born to women with laboratory evidence of recent possible Zika virus infection during pregnancy permits timely and appropriate clinical intervention services (6).
- Published
- 2017